REPH
Recro Pharma Inc
Halal Rating :
Last Price
$1.10
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Exchange
Next Earnings Date
Recro Pharma Inc is a contract development and manufacturing organization (CDMO) that provides services to pharmaceutical companies. The company specializes in the development, manufacturing, and packaging of oral solid dose drug products. Their services include formulation development, clinical and commercial manufacturing, and packaging solutions for both pharmaceutical and biotechnology companies.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2023 | $27.72m | $28.56m | - | $2.59m | 0.00% | 9.08% |
| Sept. 30, 2023 | $23.59m | $28.26m | - | $2.91m | 0.00% | 10.30% |
| June 30, 2023 | $21.8m | $25.08m | - | $2.31m | 0.00% | 9.23% |
Company Impact
Help us evaluate Recro Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.